- NETE, Mullen Technologies sign definitive merger agreement
- Newly formed company will be dedicated to development of environmentally friendly, affordable technology offering energy solutions
- Agreement calls for Net Element’s wholly owned, newly formed subsidiary to acquire all outstanding shares of Mullen
Net Element (NASDAQ: NETE), a global financial technology and value-added solutions group, has signed a definitive merger agreement with Mullen Technologies Inc. The agreement outlines a stock-for-stock reverse merger plan resulting in Mullen, a privately held electric vehicle company, and its stockholders owning a majority of the outstanding stock in the post-merger company (http://ibn.fm/5LwBp).
“We are excited to move forward with the proposed merger with Mullen Technologies,” said Net Element executive chairman…
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.